Public, NASDAQ:SCLN
NASDAQ Global Market
Difficult Obstacles for SciClone
Date: Fri, 27 Jun 2008 20:21:28 GMT
Tags:
Difficult Obstacles for SciClone
Motley Fool - Jun 27, 2008
Motley Fool - Jun 27, 2008
With all the new technologies and discoveries , some drugmakers are undoubtedly going to be left in the dust.SciClone Pharmaceuticals ( Nasdaq : SCLN ) , with its lead drug Zadaxin , might be ...
SciClone and Sigma-Tau complete enrollment of Phase III hepatitis C trial
Date: Fri, 27 Jun 2008 09:26:23 GMT
Tags:
SciClone and Sigma-Tau complete enrollment of Phase III hepatitis C trial
Trading Markets (press release) - Jun 27, 2008
Trading Markets (press release) - Jun 27, 2008
Jun 27 , 2008 ( Datamonitor via COMTEX ) - - SCLN | Quote | Chart | News | PowerRating - - SciClone Pharmaceuticals and Sigma - Tau have announced that all 553 enrolled patients successfully ...
SciClone And Sigma-Tau Provide Update On Phase 3 Hepatitis C Study
Date: Fri, 27 Jun 2008 07:08:11 GMT
Tags:
SciClone And Sigma-Tau Provide Update On Phase 3 Hepatitis C Study
Medical News Today (press release) - Jun 27, 2008
Medical News Today (press release) - Jun 27, 2008
SciClone Pharmaceuticals , Inc . ( NASDAQ : SCLN ) and Sigma - Tau SpA announced that all 553 enrolled patients successfully completed a Phase 3 trial.After 48 weeks of therapy , all patients ...
SciClone Pharma and Sigma-Tau announce successful completion of Phase 3 hepatitis C study
Date: Thu, 26 Jun 2008 17:44:12 GMT
Tags:
SciClone Pharma and Sigma-Tau announce successful completion of Phase 3 hepatitis C study
RTT News - Jun 26, 2008
RTT News - Jun 26, 2008
( RTTNews ) - Thursday , biopharmaceutical company SciClone Pharmaceuticals , Inc . ( SCLN : News , Chart , Quote ) and Sigma - Tau SpA announced the successful completion of a Phase 3 trial ...
SciClone and Sigma-Tau Update on late-stage Hepatitis C Study - quick facts - RTT NewsSciClone and Sigma-Tau Provide Update on Phase 3 Hepatitis C Study
Date: Thu, 26 Jun 2008 10:46:25 GMT
Tags:
SciClone and Sigma-Tau Provide Update on Phase 3 Hepatitis C Study
CNNMoney.com - Jun 26, 2008
CNNMoney.com - Jun 26, 2008
SciClone Pharmaceuticals , Inc . ( NASDAQ : SCLN ) and Sigma - Tau SpA today announced that all 553 enrolled patients successfully completed a Phase 3 trial.After 48 weeks of therapy , all patients ...
Difficult Obstacles for SciClone (at Motley Fool)
Date: Fri, 27 Jun 2008 20:06:33 Etc/GMT
Tags:
SciClone and Sigma-Tau Provide Update on Phase 3 Hepatitis C Study (Marketwire)
Date: Thu, 26 Jun 2008 10:30:00 Etc/GMT
Tags:
SciClone Pharmaceuticals to Hold Annual Stockholders Meeting June 10, 2008 (Marketwire)
Date: Fri, 6 Jun 2008 10:30:00 Etc/GMT
Tags:
SciClone Pharmaceuticals, Inc. today announced that it will hold its Annual Meeting of Stockholders on Tuesday, June 10, 2008 at 10:00 a.m. Pacific time. The meeting will be held at the San Mateo Marriott in San Mateo, CA. Registered stockholders are encouraged to attend. A live webcast of the stockholders meeting and corporate presentation will be available under the Investor Relations section of the Company's website at www.sciclone.com.
SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)
Date: Fri, 30 May 2008 21:03:58 Etc/GMT
Tags:
New Star Analyst Rankings for SCICLONE PHARMA (StarMine)
Date: Sun, 11 May 2008 13:33:21 Etc/GMT
Tags: